MUN — Munar Pharma SA Balance Sheet
0.000.00%
- PLN18.74m
- PLN16.93m
- PLN0.25m
Annual balance sheet for Munar Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.136 | 0.605 | 0.193 | 0.233 | 0.018 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.629 | 1.04 | 1.45 | 0.467 | 0.236 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.88 | 4.67 | 4.44 | 0.813 | 0.254 |
| Net Property, Plant And Equipment | 0.02 | 0.015 | 0.017 | 0.104 | 0 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 3.14 | 4.93 | 4.65 | 0.917 | 0.283 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.15 | 1.79 | 1.61 | 2.15 | 1.31 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.93 | 2.49 | 2.4 | 2.26 | 1.34 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.22 | 2.44 | 2.25 | -1.34 | -1.06 |
| Total Liabilities & Shareholders' Equity | 3.14 | 4.93 | 4.65 | 0.917 | 0.283 |
| Total Common Shares Outstanding |